E-therapeutics Appoints Non-Executive Chair
This article was originally published in Scrip
E-therapeutics has appointed Iain Ross to its board of directors as non-executive chair and acting chair Malcolm Young has stepped down, continuing his role as CEO. Ross brings more than 35 years' experience to e-Therapeutics and is currently non-executive director Anatara LifeSciences Ltd., non-executive chair of Premier Veterinary Group plc. and Biomer Technology Ltd. Previously, Ross held roles in Sandoz, Hoffman La Roche and Celltech Group plc., where he was CEO.
Register for our free email digests: